Neuroone Medical Technologies (NMTC) Assets Average (2011 - 2026)

Neuroone Medical Technologies has disclosed Assets Average across 15 years of filings, most recently posting $8.1 million for Q1 2026.

• Quarterly Assets Average rose 47.44% year-over-year to $8.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.1 million (up 47.44% YoY) and the FY2025 annual result came in at $8.1 million, up 19.96% from the prior year.
• Assets Average eased to $8.1 million in Q1 2026, from $9.7 million in the prior quarter.
• Across five years, Assets Average topped out at $15.6 million in Q1 2022 and bottomed at $5.1 million in Q3 2024.
• The 5-year median for Assets Average is $7.6 million (2025), against an average of $8.5 million.
• Year-over-year, Assets Average slumped 49.48% in 2023 and soared 110.11% in 2025.
• Neuroone Medical Technologies' Assets Average stood at $11.2 million in 2022, then plunged by 38.09% to $7.0 million in 2023, then slipped by 14.77% to $5.9 million in 2024, then surged by 63.2% to $9.7 million in 2025, then slipped by 16.61% to $8.1 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $8.1 million, $9.7 million, and $10.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.